Preventing impulse control side effects from Parkinson's medication
Part of Brain & nervous system, Mental health clinical trials.
This study tests a computer-based tool that aims to predict and prevent impulse control disorders (like compulsive gambling or shopping) caused by certain Parkinson's medications. If you take a dopamine agonist, this tool might help your doctor adjust your treatment to avoid these side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Parkinson's disease for less than 6 years.
- You are currently taking a dopamine agonist (a type of Parkinson's medication) for at least 2 months, with no plans to stop in the next 3 years.
- You do not have significant impulse control problems (like compulsive gambling or shopping) caused by your medication.
- You are covered by French national health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called pimavanserin to see if it helps reduce impulse control problems (like compulsive gambling or eating) in people with Parkinson's disease. If you struggle with these behaviors, this treatment might bring relief.
This trial tests whether a type of non-invasive brain stimulation called TMS can help reduce impulse control problems (like gambling or compulsive eating) that are caused by Parkinson's medications. It's for people with Parkinson's who are living with these side effects.
This trial tests whether deep brain stimulation (DBS) of the subthalamic nucleus can help control impulse control problems (like gambling, overeating, or shopping) in people with Parkinson's disease. It is for patients whose medication-related impulse symptoms are moderate to severe and who are good candidates for DBS surgery.
This early study tests whether a personalized type of noninvasive brain stimulation (called rTMS) can help people who have trouble controlling impulsive behaviors, especially related to eating. It is for adults with a BMI over 30 who do not have other major medical or mental health conditions.
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
This study uses a brain scan called MEG to look at how Parkinson's disease and impulse control disorders affect brain networks in people who have already had deep brain stimulation (DBS) surgery. You will be asked to delay your morning medication so the researchers can study your brain without the effects of the drugs.
Hear when a new Impulse Control Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.